CommentIntravenous alteplase for ischaemic stroke
References (14)
- et al.
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
Lancet
(2007) Tissue plasminogen activator for acute ischemic stroke
N Engl J Med
(1995)- et al.
Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study
JAMA
(2000) - et al.
Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study
CMAJ
(2005) - et al.
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials
Lancet
(2004) - et al.
Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort
Stroke
(1999) - et al.
Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey
Neurology
(1999)
There are more references available in the full text version of this article.
Cited by (58)
Thrombectomy for Stroke Caused by Cardiac Myxoma
2020, Journal of Stroke and Cerebrovascular DiseasesAcute Ischemic Stroke Intervention
2016, Journal of the American College of CardiologyCitation Excerpt :Although the FDA did not modify the original indication for use of IV-rtPA beyond 3 h, recent stroke guidelines from the American Heart Association (AHA) recommended using it up to 4.5 h from onset of symptoms in eligible patients (2). Despite this recommendation, the use of IV-rtPA is estimated to occur in <3% of patients presenting with AIS (9). The narrow therapeutic time window of 4.5 h is the most common reason that patients do not receive IV-rtPA, along with a few others (Table 1).
Endovascular reperfusion strategies for acute stroke
2016, JACC: Cardiovascular InterventionsRecruitment to trials of late thrombolysis: Lessons from the EXTEND study
2014, Journal of Clinical NeuroscienceIntravenous thrombolysis for ischemic stroke in recurrent oligodendroglioma: A case report
2014, Journal of Stroke and Cerebrovascular Diseases
Copyright © 2007 Elsevier Ltd. All rights reserved.